Daiwa Securities Group’s Epizyme, Inc EPZM Stock Holding History

Daiwa Securities Group’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-191	Closed	–	–	1442
2022 Q2	$0	Hold	191	–	–	﹤0.01%	1471
2022 Q1	$0	Hold	191	–	–	﹤0.01%	1445
2021 Q4	$0	Hold	191	–	–	﹤0.01%	1476
2021 Q3	$1K	Hold	191	–	–	﹤0.01%	1306
2021 Q2	$2K	Hold	191	–	–	﹤0.01%	1170
2021 Q1	$2K	Hold	191	–	–	﹤0.01%	1173
2020 Q4	$2K	Sell	191 -380	-67%	-$4.69K	﹤0.01%	1152
2020 Q3	$7K	Hold	571	–	–	﹤0.01%	1070
2020 Q2	$9K	Hold	571	–	–	﹤0.01%	1077
2020 Q1	$9K	Hold	571	–	–	﹤0.01%	1068
2019 Q4	$14K	Hold	571	–	–	﹤0.01%	1038
2019 Q3	$6K	Hold	571	–	–	﹤0.01%	1070
2019 Q2	$7K	Buy	571 +67	+13%	+$862	﹤0.01%	1077
2019 Q1	$6K	Buy	504 +121	+32%	+$1.35K	﹤0.01%	1074
2018 Q4	$2K	Hold	383	–	–	﹤0.01%	1117
2018 Q3	$4K	Hold	383	–	–	﹤0.01%	1096
2018 Q2	$5K	Hold	383	–	–	﹤0.01%	1100
2018 Q1	$7K	Buy	+383	New	+$6.47K	﹤0.01%	1060

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Daiwa Securities Group's EPZM Position: Q3 2022 in Review

Daiwa Securities Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 191 shares.

Daiwa Securities Group first reported a position in EPZM in Q1 2018 and held it in 18 quarters. The position peaked at $14K in Q4 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Daiwa Securities Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Daiwa Securities Group sold 191 Epizyme, Inc shares in Q3 2022.
Daiwa Securities Group first reported a position in Epizyme, Inc in Q1 2018 and held it in 18 quarters.
Daiwa Securities Group's Epizyme, Inc position peaked at $14K in Q4 2019.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.